US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nuvalent, Inc.

102.62

+3.583.61%

Post-market: 102.620.00000.00%17:41 EDT

Volume:567.65K

Turnover:57.82M

Market Cap:8.10B

PE:-17.54

High:103.07

Open:98.28

Low:98.28

Close:99.04

52wk High:113.02

52wk Low:63.56

Shares:78.98M

Float Shares:57.94M

Volume Ratio:1.34

T/O Rate:0.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8522

EPS(LYR):-5.8522

ROE:-36.70%

ROA:-20.27%

PB:6.49

PE(LYR):-17.54

Loading ...

Overview Company News Filings

Nuvalent Chief Legal Officer Deborah Ann Miller sells $545,331 of common shares

Nuvalent Chief Development Officer Darlene Noci sells USD 545,251 shares

Guardant Health partners with Nuvalent on companion diagnostics development, commercialization support

Canaccord Genuity Sticks to Their Buy Rating for Nuvalent (NUVL)

Nuvalent announces annual shareholder meeting in virtual format

A Look At Nuvalent (NUVL) Valuation As Zidesamtinib NDA Acceptance Advances Late Stage Pipeline

Simply Wall St.

Nuvalent to present pivotal ALKOVE-1 neladalkib data in ALK+ NSCLC at ASCO 2026

Nuvalent Price Target Maintained With a $155.00/Share by HC Wainwright & Co.

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Nuvalent (NUVL)

BRIEF-Nuvalent, Inc - Nuvalent Anticipates U.S. Commercial Launch Of Zidesamtinib In 2026

Nuvalent to present preclinical data for zidesamtinib at AACR meeting

Nuvalent says zidesamtinib shows 41% response rate in pretreated ROS1+ lung cancer trial

Nuvalent, Inc - Nuvalent Anticipates U.S. Commercial Launch of Zidesamtinib in 2026

THOMSON REUTERS

Nuvalent says FDA accepts zidesamtinib NDA, sets Sept. 18 PDUFA date

Nuvalent CSO Henry Pelish disposes of USD 323,112 common shares

Nuvalent CEO James Porter disposes of USD 3.1 million Class A shares

Nuvalent Price Target Maintained With a $125.00/Share by Wedbush

BRIEF-Nuvalent Announces Submission Of New Drug Application To FDA For Neladalkib In Tki Pre-Treated Advanced Alk-Positive Nsclc

Nuvalent submits FDA NDA for neladalkib in pretreated ALK-positive lung cancer

Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in Tki Pre-Treated Advanced Alk-Positive Nsclc

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NUVL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":102.62,"timestamp":1777924800000,"preClose":99.04,"halted":0,"volume":567645,"hourTrading":{"tag":"盘后","latestPrice":102.62,"preClose":102.62,"latestTime":"17:41 EDT","volume":13671,"amount":1402920.02,"timestamp":1777930900640,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.036147011308562176,"floatShares":57942920,"shares":78978000,"eps":-5.852194,"marketStatus":"Closed","change":3.58,"latestTime":"05-04 16:00:00 EDT","open":98.28,"high":103.07,"low":98.28,"amount":57824616.77265,"amplitude":0.048364,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.852194,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777968000000},"marketStatusCode":5,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":99.04,"preHourTrading":{"tag":"盘前","latestPrice":98.84,"preClose":99.04,"latestTime":"08:34 EDT","volume":68,"amount":6745.32052,"timestamp":1777898082859,"change":-0.2,"changeRate":-0.002019,"amplitude":0.021002},"postHourTrading":{"tag":"盘后","latestPrice":102.62,"preClose":102.62,"latestTime":"17:41 EDT","volume":13671,"amount":1402920.02,"timestamp":1777930900640,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.339883,"impliedVol":0.4345,"impliedVolPercentile":0.4582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","floatShares":57942920,"roa":"-20.27%","roe":"-36.70%","lyrEps":-5.852194,"volumeRatio":1.339883,"shares":78978000,"dividePrice":0,"high":103.07,"amplitude":0.048364,"preClose":99.04,"low":98.28,"week52Low":63.555,"pbRate":"6.49","week52High":113.015,"institutionHeld":0,"latestPrice":102.62,"eps":-5.852194,"divideRate":0,"volume":567645,"delay":0,"ttmEps":-5.852194,"open":98.28,"prevYearClose":100.59,"prevWeekClose":99.04,"prevMonthClose":100.28,"prevQuarterClose":102.45,"fiveDayClose":104.04,"twentyDayClose":103.71,"sixtyDayClose":100.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NUVL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"NUVL","fiscalQuarterEnding":"2025/12","expectedEps":-1.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-1.29},{"market":"US","date":"2025-10-30","symbol":"NUVL","fiscalQuarterEnding":"2025/09","expectedEps":-1.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":-1.7},{"market":"US","date":"2025-05-08","symbol":"NUVL","fiscalQuarterEnding":"2025/03","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-1.18},{"market":"US","date":"2021-09-08","symbol":"NUVL","fiscalQuarterEnding":"2021/06","expectedEps":-0.21,"name":null,"time":"","type":"earning","dateTimestamp":1631073600000,"reportTimeType":"","actualEps":-3.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NUVL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2778,"buy":0.7222,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7222,"analysts":18,"updateTime":1775102400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NUVL","date":"2026-05-01","current":-17.535304,"percent":0.748288,"low":-69.351693,"twenty":-34.238295,"median":-23.961531,"eighty":-17.656648,"high":-6.26114,"avg":-25.689751,"sd":10.459861,"marketCap":7883712860},"quantilePoints":[{"date":"2021-07-30","current":-32.003439,"twenty":-32.354161,"median":-30.636831,"eighty":-29.270224,"marketCap":854491809},{"date":"2021-08-06","current":-39.893047,"twenty":-43.683429,"median":-39.621789,"eighty":-30.910153,"marketCap":1065144356},{"date":"2021-08-13","current":-40.471731,"twenty":-41.958227,"median":-39.504244,"eighty":-32.529523,"marketCap":1080595226},{"date":"2021-08-20","current":-48.862653,"twenty":-46.591318,"median":-40.471731,"eighty":-36.252451,"marketCap":1304632842},{"date":"2021-08-27","current":-62.732992,"twenty":-50.544455,"median":-43.437488,"eighty":-38.56569,"marketCap":1674970884},{"date":"2021-09-03","current":-68.881512,"twenty":-60.248267,"median":-45.860729,"eighty":-39.075655,"marketCap":1839136379},{"date":"2021-09-10","current":-65.348412,"twenty":-63.759706,"median":-47.741452,"eighty":-39.480734,"marketCap":1828513906},{"date":"2021-09-17","current":-62.94983,"twenty":-64.761708,"median":-50.860923,"eighty":-39.730292,"marketCap":1761399189},{"date":"2021-09-24","current":-39.44718,"twenty":-64.530478,"median":-49.278583,"eighty":-39.730292,"marketCap":1103771531},{"date":"2021-10-01","current":-41.63869,"twenty":-64.170784,"median":-47.714326,"eighty":-39.410891,"marketCap":1165092171},{"date":"2021-10-08","current":-31.371379,"twenty":-63.759706,"median":-45.860729,"eighty":-38.543989,"marketCap":877802556},{"date":"2021-10-15","current":-34.391176,"twenty":-63.187962,"median":-44.468269,"eighty":-35.519718,"marketCap":962299502},{"date":"2021-10-22","current":-34.529224,"twenty":-62.863095,"median":-42.812096,"eighty":-35.340256,"marketCap":966162219},{"date":"2021-10-29","current":-42.156369,"twenty":-62.364081,"median":-41.897529,"eighty":-36.171994,"marketCap":1179577362},{"date":"2021-11-05","current":-50.180402,"twenty":-61.727974,"median":-42.812096,"eighty":-36.430833,"marketCap":1404097818},{"date":"2021-11-12","current":-34.028754,"twenty":-60.644972,"median":-42.648165,"eighty":-36.184709,"marketCap":1212410461},{"date":"2021-11-19","current":-33.039467,"twenty":-58.433025,"median":-41.63869,"eighty":-35.340256,"marketCap":1177163164},{"date":"2021-11-26","current":-27.740684,"twenty":-57.008396,"median":-40.965706,"eighty":-34.418786,"marketCap":988372845},{"date":"2021-12-03","current":-27.063091,"twenty":-55.474121,"median":-40.006605,"eighty":-33.154505,"marketCap":964230860},{"date":"2021-12-10","current":-29.08232,"twenty":-53.340223,"median":-39.44718,"eighty":-32.23948,"marketCap":1036173974},{"date":"2021-12-17","current":-30.952478,"twenty":-52.342712,"median":-39.01578,"eighty":-31.220564,"marketCap":1102805851},{"date":"2021-12-23","current":-26.0467,"twenty":-51.940512,"median":-38.554839,"eighty":-29.461772,"marketCap":928017884},{"date":"2021-12-31","current":-25.802767,"twenty":-50.991433,"median":-38.204749,"eighty":-29.258494,"marketCap":919326769},{"date":"2022-01-07","current":-19.785735,"twenty":-50.180402,"median":-37.074482,"eighty":-28.635108,"marketCap":704945947},{"date":"2022-01-14","current":-17.210879,"twenty":-49.278583,"median":-36.755246,"eighty":-27.835548,"marketCap":613206406},{"date":"2022-01-21","current":-16.723012,"twenty":-48.945839,"median":-36.461894,"eighty":-27.290762,"marketCap":595824177},{"date":"2022-01-28","current":-17.590331,"twenty":-48.274083,"median":-36.023835,"eighty":-26.393628,"marketCap":626725917},{"date":"2022-02-04","current":-19.528249,"twenty":-47.81855,"median":-34.8916,"eighty":-26.000624,"marketCap":695771993},{"date":"2022-02-11","current":-24.325612,"twenty":-47.698051,"median":-34.304828,"eighty":-25.474811,"marketCap":866697243},{"date":"2022-02-18","current":-24.108782,"twenty":-47.445386,"median":-33.614657,"eighty":-24.726748,"marketCap":858971808},{"date":"2022-02-25","current":-21.018955,"twenty":-46.753363,"median":-32.880245,"eighty":-23.908215,"marketCap":748884359},{"date":"2022-03-04","current":-20.463328,"twenty":-46.073478,"median":-32.376852,"eighty":-22.116657,"marketCap":729087931},{"date":"2022-03-11","current":-21.005403,"twenty":-45.876805,"median":-31.765591,"eighty":-21.612527,"marketCap":748401519},{"date":"2022-03-18","current":-16.289352,"twenty":-45.336102,"median":-31.130443,"eighty":-21.013534,"marketCap":580373307},{"date":"2022-03-25","current":-17.102464,"twenty":-44.94676,"median":-29.461772,"eighty":-20.382017,"marketCap":609343688},{"date":"2022-04-01","current":-15.39984,"twenty":-44.68041,"median":-29.270224,"eighty":-19.994434,"marketCap":713597794},{"date":"2022-04-08","current":-13.710758,"twenty":-44.217879,"median":-29.08232,"eighty":-18.704295,"marketCap":635329113},{"date":"2022-04-14","current":-12.397028,"twenty":-43.553225,"median":-28.729971,"eighty":-18.145958,"marketCap":574453471},{"date":"2022-04-22","current":-11.343958,"twenty":-42.840121,"median":-28.228552,"eighty":-17.273218,"marketCap":525656330},{"date":"2022-04-29","current":-10.728799,"twenty":-42.680951,"median":-27.835548,"eighty":-17.086202,"marketCap":497151070},{"date":"2022-05-06","current":-10.926901,"twenty":-42.353087,"median":-27.38156,"eighty":-16.790771,"marketCap":506330730},{"date":"2022-05-13","current":-6.7688,"twenty":-41.949297,"median":-26.954676,"eighty":-16.549548,"marketCap":386512008},{"date":"2022-05-20","current":-6.819566,"twenty":-41.526351,"median":-26.487136,"eighty":-16.27309,"marketCap":389410848},{"date":"2022-05-27","current":-7.987184,"twenty":-41.200988,"median":-26.0467,"eighty":-15.742753,"marketCap":456084169},{"date":"2022-06-03","current":-7.775659,"twenty":-40.866911,"median":-26.033148,"eighty":-14.722122,"marketCap":444005669},{"date":"2022-06-10","current":-7.919496,"twenty":-40.401417,"median":-25.836647,"eighty":-13.721184,"marketCap":452219049},{"date":"2022-06-17","current":-8.477922,"twenty":-40.07474,"median":-25.545281,"eighty":-12.528401,"marketCap":484106290},{"date":"2022-06-24","current":-11.498499,"twenty":-39.893047,"median":-24.827032,"eighty":-12.282337,"marketCap":656587273},{"date":"2022-07-01","current":-11.464655,"twenty":-39.621789,"median":-24.09523,"eighty":-11.740163,"marketCap":654654713},{"date":"2022-07-08","current":-15.39902,"twenty":-39.482102,"median":-23.614139,"eighty":-11.765186,"marketCap":879314818},{"date":"2022-07-15","current":-14.121409,"twenty":-39.398794,"median":-22.27928,"eighty":-11.796764,"marketCap":806360676},{"date":"2022-07-22","current":-12.903025,"twenty":-39.172792,"median":-21.750757,"eighty":-11.911231,"marketCap":736788515},{"date":"2022-07-29","current":-12.573046,"twenty":-38.953658,"median":-21.547478,"eighty":-12.213523,"marketCap":717946054},{"date":"2022-08-05","current":-13.613749,"twenty":-38.669722,"median":-21.018955,"eighty":-12.041695,"marketCap":777372276},{"date":"2022-08-12","current":-12.344485,"twenty":-38.522289,"median":-20.829229,"eighty":-12.041695,"marketCap":811402986},{"date":"2022-08-19","current":-11.814173,"twenty":-38.3924,"median":-20.361689,"eighty":-12.011358,"marketCap":776545578},{"date":"2022-08-26","current":-11.593209,"twenty":-38.23687,"median":-20.124532,"eighty":-11.962731,"marketCap":762021658},{"date":"2022-09-02","current":-12.337119,"twenty":-37.455071,"median":-19.873822,"eighty":-11.913447,"marketCap":810918855},{"date":"2022-09-09","current":-12.955817,"twenty":-37.250109,"median":-19.121693,"eighty":-11.888628,"marketCap":851585830},{"date":"2022-09-16","current":-13.022106,"twenty":-37.041696,"median":-18.281477,"eighty":-11.956614,"marketCap":855943006},{"date":"2022-09-23","current":-12.35185,"twenty":-36.880877,"median":-17.841041,"eighty":-11.986524,"marketCap":811887116},{"date":"2022-09-30","current":-14.318424,"twenty":-36.797586,"median":-17.305742,"eighty":-12.008096,"marketCap":941150003},{"date":"2022-10-07","current":-13.684996,"twenty":-36.724185,"median":-17.197327,"eighty":-12.034926,"marketCap":899514766},{"date":"2022-10-14","current":-15.268566,"twenty":-36.558528,"median":-17.07536,"eighty":-12.071402,"marketCap":1003602858},{"date":"2022-10-21","current":-14.649869,"twenty":-36.430833,"median":-16.885634,"eighty":-12.126467,"marketCap":962935882},{"date":"2022-10-28","current":-26.02948,"twenty":-36.184709,"median":-16.736563,"eighty":-12.171497,"marketCap":1710917752},{"date":"2022-11-04","current":-26.315342,"twenty":-36.021716,"median":-16.933065,"eighty":-12.236034,"marketCap":1729707455},{"date":"2022-11-11","current":-24.734689,"twenty":-35.340256,"median":-17.102464,"eighty":-12.277734,"marketCap":1806127008},{"date":"2022-11-18","current":-23.845786,"twenty":-34.8916,"median":-17.231207,"eighty":-12.315206,"marketCap":1741219318},{"date":"2022-11-25","current":-24.927929,"twenty":-34.74665,"median":-17.380277,"eighty":-12.340065,"marketCap":1820237375},{"date":"2022-12-02","current":-27.849714,"twenty":-34.474005,"median":-18.091751,"eighty":-12.347431,"marketCap":2033586128},{"date":"2022-12-09","current":-23.96946,"twenty":-34.322098,"median":-18.484755,"eighty":-12.360689,"marketCap":1750249953},{"date":"2022-12-16","current":-22.856399,"twenty":-34.14259,"median":-19.528249,"eighty":-12.383179,"marketCap":1668974238},{"date":"2022-12-23","current":-21.982955,"twenty":-33.863115,"median":-19.989013,"eighty":-12.401198,"marketCap":1605195378},{"date":"2022-12-30","current":-23.01872,"twenty":-33.499619,"median":-20.151635,"eighty":-12.411064,"marketCap":1680826946},{"date":"2023-01-06","current":-21.526909,"twenty":-33.039467,"median":-20.361689,"eighty":-12.425505,"marketCap":1571894911},{"date":"2023-01-13","current":-25.067062,"twenty":-32.880245,"median":-20.692113,"eighty":-12.43287,"marketCap":1830396839},{"date":"2023-01-20","current":-23.868975,"twenty":-32.667097,"median":-20.829229,"eighty":-12.43287,"marketCap":1742912562},{"date":"2023-01-27","current":-25.09025,"twenty":-32.607408,"median":-21.018955,"eighty":-12.454243,"marketCap":1832090083},{"date":"2023-02-03","current":-23.242878,"twenty":-32.23948,"median":-21.295022,"eighty":-12.497137,"marketCap":1697194972},{"date":"2023-02-10","current":-22.160736,"twenty":-32.032331,"median":-21.41483,"eighty":-12.512417,"marketCap":1618176916},{"date":"2023-02-17","current":-25.144358,"twenty":-31.813161,"median":-21.547478,"eighty":-12.561215,"marketCap":1836040986},{"date":"2023-02-24","current":-23.258337,"twenty":-31.529064,"median":-21.655893,"eighty":-12.61268,"marketCap":1698323802},{"date":"2023-03-03","current":-23.150123,"twenty":-31.258268,"median":-21.825291,"eighty":-12.655311,"marketCap":1690421996},{"date":"2023-03-10","current":-20.483415,"twenty":-31.11996,"median":-21.77786,"eighty":-12.694101,"marketCap":1495698928},{"date":"2023-03-17","current":-21.066674,"twenty":-31.002698,"median":-21.750757,"eighty":-12.767298,"marketCap":1724391538},{"date":"2023-03-24","current":-19.133888,"twenty":-30.058054,"median":-21.655893,"eighty":-12.828665,"marketCap":1566185277},{"date":"2023-03-31","current":-18.073973,"twenty":-29.453641,"median":-21.544923,"eighty":-12.858593,"marketCap":1479427005},{"date":"2023-04-06","current":-16.335159,"twenty":-29.377022,"median":-21.488261,"eighty":-12.867431,"marketCap":1337098075},{"date":"2023-04-14","current":-19.85701,"twenty":-29.270224,"median":-21.3442,"eighty":-12.881669,"marketCap":1625375676},{"date":"2023-04-21","current":-23.2682,"twenty":-29.265532,"median":-21.362124,"eighty":-12.924142,"marketCap":1904595240},{"date":"2023-04-28","current":-23.815932,"twenty":-29.188024,"median":-21.526909,"eighty":-12.97644,"marketCap":1949429276},{"date":"2023-05-04","current":-25.759189,"twenty":-29.047085,"median":-21.547478,"eighty":-13.010321,"marketCap":2108492618},{"date":"2023-05-12","current":-25.430668,"twenty":-28.87091,"median":-21.684156,"eighty":-13.022106,"marketCap":2275968472},{"date":"2023-05-19","current":-24.709927,"twenty":-28.710998,"median":-21.777538,"eighty":-13.036805,"marketCap":2211464368},{"date":"2023-05-26","current":-24.551205,"twenty":-28.635108,"median":-21.836093,"eighty":-13.095599,"marketCap":2197259175},{"date":"2023-06-02","current":-26.982834,"twenty":-28.385754,"median":-21.975225,"eighty":-13.131082,"marketCap":2414882725},{"date":"2023-06-09","current":-26.976485,"twenty":-28.315219,"median":-21.998414,"eighty":-13.150094,"marketCap":2414314517},{"date":"2023-06-16","current":-28.366895,"twenty":-28.315219,"median":-22.102764,"eighty":-13.18266,"marketCap":2538752003},{"date":"2023-06-23","current":-26.709832,"twenty":-28.306861,"median":-22.335952,"eighty":-13.208307,"marketCap":2390449793},{"date":"2023-06-30","current":-27.198697,"twenty":-28.268754,"median":-22.446731,"eighty":-13.258915,"marketCap":2434201786},{"date":"2023-07-07","current":-25.414655,"twenty":-28.133689,"median":-22.531756,"eighty":-13.410685,"marketCap":2274535423},{"date":"2023-07-14","current":-26.627296,"twenty":-28.013291,"median":-22.709537,"eighty":-13.436068,"marketCap":2383063093},{"date":"2023-07-21","current":-28.538315,"twenty":-28.133689,"median":-22.767353,"eighty":-13.469912,"marketCap":2554093611},{"date":"2023-07-28","current":-29.477953,"twenty":-28.312487,"median":-22.83321,"eighty":-13.57127,"marketCap":2638188351},{"date":"2023-08-04","current":-28.862109,"twenty":-28.557674,"median":-22.893801,"eighty":-13.610321,"marketCap":2583072204},{"date":"2023-08-11","current":-24.764415,"twenty":-28.557674,"median":-23.065098,"eighty":-13.658962,"marketCap":2479438043},{"date":"2023-08-18","current":-23.414561,"twenty":-28.426575,"median":-23.157853,"eighty":-13.68205,"marketCap":2344289281},{"date":"2023-08-25","current":-23.824644,"twenty":-28.373244,"median":-23.263269,"eighty":-13.705606,"marketCap":2385347133},{"date":"2023-09-01","current":-25.954793,"twenty":-28.336421,"median":-23.39747,"eighty":-13.749072,"marketCap":2598619862},{"date":"2023-09-08","current":-26.99139,"twenty":-28.32557,"median":-23.414561,"eighty":-13.761194,"marketCap":2702404987},{"date":"2023-09-15","current":-27.338821,"twenty":-28.315219,"median":-23.555926,"eighty":-13.769146,"marketCap":2737190112},{"date":"2023-09-22","current":-24.587852,"twenty":-28.305414,"median":-23.621628,"eighty":-13.830806,"marketCap":2461760356},{"date":"2023-09-29","current":-26.518657,"twenty":-28.280196,"median":-23.696285,"eighty":-13.88343,"marketCap":2655074408},{"date":"2023-10-06","current":-35.546163,"twenty":-28.305414,"median":-23.77622,"eighty":-13.903115,"marketCap":3558917393},{"date":"2023-10-13","current":-34.236178,"twenty":-28.379593,"median":-23.8154,"eighty":-13.955573,"marketCap":3427760367},{"date":"2023-10-20","current":-29.064584,"twenty":-28.744733,"median":-23.845786,"eighty":-14.026646,"marketCap":2909975237},{"date":"2023-10-27","current":-33.614382,"twenty":-28.862109,"median":-23.861246,"eighty":-14.053721,"marketCap":3365505501},{"date":"2023-11-03","current":-34.337138,"twenty":-29.211299,"median":-23.903358,"eighty":-14.060633,"marketCap":3437868548},{"date":"2023-11-10","current":-35.464886,"twenty":-29.44822,"median":-23.947665,"eighty":-14.060633,"marketCap":3550779854},{"date":"2023-11-17","current":-31.866939,"twenty":-29.833491,"median":-23.964282,"eighty":-14.121409,"marketCap":3634424412},{"date":"2023-11-24","current":-34.755447,"twenty":-30.824236,"median":-23.993876,"eighty":-14.178851,"marketCap":3963858712},{"date":"2023-12-01","current":-35.89767,"twenty":-31.144585,"median":-24.054485,"eighty":-14.230533,"marketCap":4094129310},{"date":"2023-12-08","current":-38.896007,"twenty":-31.669705,"median":-24.123342,"eighty":-14.266938,"marketCap":4436089628},{"date":"2023-12-15","current":-43.38253,"twenty":-31.894239,"median":-24.22903,"eighty":-14.297696,"marketCap":4947777505},{"date":"2023-12-22","current":-38.720281,"twenty":-32.410785,"median":-24.257295,"eighty":-14.315478,"marketCap":4416047998},{"date":"2023-12-29","current":-41.224386,"twenty":-32.610609,"median":-24.317291,"eighty":-14.330209,"marketCap":4701641231},{"date":"2024-01-05","current":-39.862504,"twenty":-32.805979,"median":-24.337125,"eighty":-14.347886,"marketCap":4546318596},{"date":"2024-01-12","current":-40.768595,"twenty":-33.028713,"median":-24.382811,"eighty":-14.347886,"marketCap":4649658252},{"date":"2024-01-19","current":-40.362227,"twenty":-33.4798,"median":-24.425506,"eighty":-14.383306,"marketCap":4603311982},{"date":"2024-01-26","current":-41.899836,"twenty":-34.069015,"median":-24.465511,"eighty":-14.439543,"marketCap":4778676248},{"date":"2024-02-02","current":-42.657657,"twenty":-34.347946,"median":-24.545441,"eighty":-14.462864,"marketCap":4865105779},{"date":"2024-02-09","current":-44.25018,"twenty":-34.775757,"median":-24.580747,"eighty":-14.478998,"marketCap":5046733055},{"date":"2024-02-16","current":-46.402832,"twenty":-34.95921,"median":-24.709927,"eighty":-14.504403,"marketCap":5292243027},{"date":"2024-02-23","current":-45.705417,"twenty":-35.262302,"median":-24.734689,"eighty":-14.556028,"marketCap":5212702806},{"date":"2024-03-01","current":-42.698561,"twenty":-35.546163,"median":-24.77209,"eighty":-14.598111,"marketCap":5389369708},{"date":"2024-03-08","current":-42.363551,"twenty":-36.021716,"median":-24.804256,"eighty":-14.610096,"marketCap":5347085067},{"date":"2024-03-15","current":-42.942205,"twenty":-36.558528,"median":-24.831986,"eighty":-14.622658,"marketCap":5420122174},{"date":"2024-03-22","current":-40.373794,"twenty":-36.868914,"median":-24.992974,"eighty":-14.641549,"marketCap":5095939926},{"date":"2024-03-28","current":-38.90178,"twenty":-37.200741,"median":-25.005225,"eighty":-14.658707,"marketCap":4910143776},{"date":"2024-04-05","current":-36.495798,"twenty":-37.374818,"median":-25.061735,"eighty":-14.675345,"marketCap":4606463172},{"date":"2024-04-12","current":-34.516193,"twenty":-37.267525,"median":-25.09025,"eighty":-14.735959,"marketCap":4356599384},{"date":"2024-04-19","current":-32.008693,"twenty":-37.255768,"median":-25.199563,"eighty":-14.847142,"marketCap":4040105252},{"date":"2024-04-26","current":-33.536542,"twenty":-37.200741,"median":-25.298949,"eighty":-14.916986,"marketCap":4232948842},{"date":"2024-05-03","current":-37.038357,"twenty":-37.101882,"median":-25.381429,"eighty":-14.992892,"marketCap":4674944398},{"date":"2024-05-10","current":-29.955741,"twenty":-36.987234,"median":-25.430668,"eighty":-15.077502,"marketCap":4358829897},{"date":"2024-05-17","current":-32.227266,"twenty":-36.898587,"median":-25.520776,"eighty":-15.184387,"marketCap":4689357283},{"date":"2024-05-24","current":-29.583069,"twenty":-36.872823,"median":-25.569485,"eighty":-15.320748,"marketCap":4304602748},{"date":"2024-05-31","current":-29.494337,"twenty":-36.839925,"median":-25.653696,"eighty":-15.399184,"marketCap":4291691522},{"date":"2024-06-07","current":-36.206872,"twenty":-36.753783,"median":-25.749363,"eighty":-15.460497,"marketCap":5268425769},{"date":"2024-06-14","current":-35.040054,"twenty":-36.747932,"median":-25.822877,"eighty":-15.703127,"marketCap":5098643147},{"date":"2024-06-21","current":-34.782732,"twenty":-36.712369,"median":-25.874326,"eighty":-15.710732,"marketCap":5061200592},{"date":"2024-06-28","current":-34.148302,"twenty":-36.661942,"median":-25.890823,"eighty":-15.727693,"marketCap":4968885326},{"date":"2024-07-05","current":-31.965508,"twenty":-36.495798,"median":-25.923936,"eighty":-15.787932,"marketCap":4651269166},{"date":"2024-07-12","current":-34.600833,"twenty":-36.461894,"median":-25.988967,"eighty":-15.815036,"marketCap":5034732578},{"date":"2024-07-15","current":-34.893647,"twenty":-36.45154,"median":-26.009223,"eighty":-15.833901,"marketCap":5077339624},{"date":"2024-08-02","current":-33.815559,"twenty":-36.441187,"median":-26.02948,"eighty":-15.852766,"marketCap":4920468228},{"date":"2024-08-09","current":-26.219913,"twenty":-36.38746,"median":-26.039924,"eighty":-15.936679,"marketCap":4551383634},{"date":"2024-08-16","current":-26.843308,"twenty":-36.294826,"median":-26.091487,"eighty":-16.068186,"marketCap":4659595631},{"date":"2024-08-23","current":-30.983098,"twenty":-36.163411,"median":-26.131203,"eighty":-16.227286,"marketCap":5378201049},{"date":"2024-08-30","current":-31.916324,"twenty":-36.072704,"median":-26.182617,"eighty":-16.27309,"marketCap":5540195056},{"date":"2024-09-06","current":-31.714747,"twenty":-36.030193,"median":-26.219913,"eighty":-16.289352,"marketCap":5505204350},{"date":"2024-09-13","current":-30.490355,"twenty":-36.010736,"median":-26.305926,"eighty":-16.294773,"marketCap":5292668213},{"date":"2024-09-20","current":-41.470105,"twenty":-36.185141,"median":-26.404281,"eighty":-16.320196,"marketCap":7198588141},{"date":"2024-09-27","current":-41.023082,"twenty":-36.489017,"median":-26.487136,"eighty":-16.335438,"marketCap":7120991681},{"date":"2024-10-04","current":-42.063985,"twenty":-36.839925,"median":-26.521016,"eighty":-16.36506,"marketCap":7301676910},{"date":"2024-10-11","current":-41.629121,"twenty":-37.123057,"median":-26.535236,"eighty":-16.487703,"marketCap":7226190975},{"date":"2024-10-18","current":-41.519389,"twenty":-37.41054,"median":-26.571994,"eighty":-16.548812,"marketCap":7207143122},{"date":"2024-10-25","current":-38.052666,"twenty":-38.109047,"median":-26.647191,"eighty":-16.659123,"marketCap":6605372068},{"date":"2024-10-31","current":-36.674918,"twenty":-38.085179,"median":-26.68862,"eighty":-16.674608,"marketCap":6366215694},{"date":"2024-11-08","current":-38.239617,"twenty":-38.115014,"median":-26.712656,"eighty":-16.695908,"marketCap":6637823966},{"date":"2024-11-15","current":-28.56865,"twenty":-38.204749,"median":-26.80059,"eighty":-16.723012,"marketCap":6407519770},{"date":"2024-11-22","current":-29.37648,"twenty":-38.115014,"median":-26.887601,"eighty":-16.736563,"marketCap":6588703796},{"date":"2024-11-29","current":-30.627824,"twenty":-38.091146,"median":-26.954676,"eighty":-16.844978,"marketCap":6869361404},{"date":"2024-12-06","current":-29.693276,"twenty":-38.059169,"median":-26.97966,"eighty":-16.893765,"marketCap":6659756355},{"date":"2024-12-13","current":-27.504216,"twenty":-37.747042,"median":-27.063091,"eighty":-16.953393,"marketCap":6168783172},{"date":"2024-12-20","current":-26.813601,"twenty":-37.583519,"median":-27.063095,"eighty":-17.053677,"marketCap":6013888593},{"date":"2024-12-27","current":-25.996268,"twenty":-37.492453,"median":-26.987112,"eighty":-17.091622,"marketCap":5830572991},{"date":"2025-01-03","current":-25.340501,"twenty":-37.40921,"median":-26.975395,"eighty":-17.134988,"marketCap":5683494194},{"date":"2025-01-10","current":-24.789276,"twenty":-37.336436,"median":-26.943787,"eighty":-17.189196,"marketCap":5559862741},{"date":"2025-01-17","current":-24.073317,"twenty":-37.267588,"median":-26.849001,"eighty":-17.21901,"marketCap":5399283958},{"date":"2025-01-24","current":-26.515813,"twenty":-37.267337,"median":-26.813601,"eighty":-17.251535,"marketCap":5947099188},{"date":"2025-01-31","current":-27.798837,"twenty":-37.238414,"median":-26.828454,"eighty":-17.305742,"marketCap":6234862052},{"date":"2025-02-07","current":-27.466201,"twenty":-37.144232,"median":-26.880129,"eighty":-17.454813,"marketCap":6160256865},{"date":"2025-02-14","current":-25.644625,"twenty":-37.038357,"median":-26.846155,"eighty":-17.471277,"marketCap":5751704651},{"date":"2025-02-21","current":-26.100811,"twenty":-36.968696,"median":-26.785736,"eighty":-17.56652,"marketCap":5854020336},{"date":"2025-02-28","current":-20.411984,"twenty":-36.918696,"median":-26.712656,"eighty":-17.605929,"marketCap":5322547194},{"date":"2025-03-07","current":-20.027736,"twenty":-36.886624,"median":-26.694963,"eighty":-17.787173,"marketCap":5222352284},{"date":"2025-03-14","current":-20.450586,"twenty":-36.865624,"median":-26.667087,"eighty":-17.99777,"marketCap":5332613081},{"date":"2025-03-21","current":-21.318253,"twenty":-36.86125,"median":-26.590122,"eighty":-18.067045,"marketCap":5558862508},{"date":"2025-03-28","current":-20.214449,"twenty":-36.776416,"median":-26.54476,"eighty":-18.073973,"marketCap":5271038870},{"date":"2025-04-04","current":-18.759184,"twenty":-36.749395,"median":-26.523364,"eighty":-18.088195,"marketCap":4891569894},{"date":"2025-04-11","current":-17.021104,"twenty":-36.712369,"median":-26.515813,"eighty":-17.99777,"marketCap":4438355060},{"date":"2025-04-17","current":-19.212238,"twenty":-36.686342,"median":-26.48036,"eighty":-18.046198,"marketCap":5009706462},{"date":"2025-04-25","current":-20.313297,"twenty":-36.567446,"median":-26.420448,"eighty":-18.064693,"marketCap":5296814121},{"date":"2025-05-02","current":-20.931098,"twenty":-36.475456,"median":-26.315342,"eighty":-18.073973,"marketCap":5457909441},{"date":"2025-05-09","current":-17.089596,"twenty":-36.430833,"median":-26.28219,"eighty":-18.073973,"marketCap":5141507574},{"date":"2025-05-16","current":-16.946387,"twenty":-36.395868,"median":-26.219913,"eighty":-17.80499,"marketCap":5098422315},{"date":"2025-05-23","current":-17.478647,"twenty":-36.366622,"median":-26.183178,"eighty":-17.602029,"marketCap":5258555860},{"date":"2025-05-30","current":-17.84383,"twenty":-36.316227,"median":-26.173393,"eighty":-17.576984,"marketCap":5368423271},{"date":"2025-06-06","current":-18.638639,"twenty":-36.238974,"median":-26.132081,"eighty":-17.5849,"marketCap":5607546458},{"date":"2025-06-13","current":-18.595677,"twenty":-36.163411,"median":-26.113701,"eighty":-17.59813,"marketCap":5594620881},{"date":"2025-06-20","current":-18.027615,"twenty":-36.085461,"median":-26.070805,"eighty":-17.639806,"marketCap":5423716020},{"date":"2025-06-27","current":-18.886868,"twenty":-36.030193,"median":-26.0467,"eighty":-17.760818,"marketCap":5682227574},{"date":"2025-07-03","current":-19.209088,"twenty":-36.013239,"median":-26.033148,"eighty":-17.765211,"marketCap":5779169407},{"date":"2025-07-11","current":-19.588592,"twenty":-36.000722,"median":-25.992618,"eighty":-17.808028,"marketCap":5893345343},{"date":"2025-07-18","current":-20.452619,"twenty":-35.944936,"median":-25.938285,"eighty":-17.831509,"marketCap":6153293072},{"date":"2025-07-25","current":-19.590979,"twenty":-35.89767,"median":-25.890823,"eighty":-17.84383,"marketCap":5894063431},{"date":"2025-08-01","current":-18.700696,"twenty":-35.632894,"median":-25.842988,"eighty":-17.901113,"marketCap":5626216737},{"date":"2025-08-08","current":-15.091965,"twenty":-35.546163,"median":-25.760514,"eighty":-17.901113,"marketCap":5181720482},{"date":"2025-08-15","current":-16.128628,"twenty":-35.546163,"median":-25.736495,"eighty":-17.765211,"marketCap":5537651481},{"date":"2025-08-22","current":-15.467102,"twenty":-35.531375,"median":-25.649161,"eighty":-17.58128,"marketCap":5310521245},{"date":"2025-08-29","current":-15.964821,"twenty":-35.519203,"median":-25.58458,"eighty":-17.497742,"marketCap":5481409708},{"date":"2025-09-05","current":-16.731351,"twenty":-35.510641,"median":-25.545281,"eighty":-17.424999,"marketCap":5744592363},{"date":"2025-09-12","current":-17.266872,"twenty":-35.50464,"median":-25.47316,"eighty":-17.241786,"marketCap":5928459698},{"date":"2025-09-19","current":-17.002262,"twenty":-35.503675,"median":-25.430668,"eighty":-17.086749,"marketCap":5837607603},{"date":"2025-09-26","current":-16.279834,"twenty":-35.472644,"median":-25.414774,"eighty":-17.026191,"marketCap":5589566964},{"date":"2025-10-03","current":-17.611286,"twenty":-35.429994,"median":-25.348204,"eighty":-17.0428,"marketCap":6046711630},{"date":"2025-10-10","current":-18.480719,"twenty":-35.390572,"median":-25.316462,"eighty":-17.048543,"marketCap":6345225656},{"date":"2025-10-17","current":-18.988939,"twenty":-35.231658,"median":-25.206194,"eighty":-17.070092,"marketCap":6519719361},{"date":"2025-10-24","current":-19.087643,"twenty":-35.163828,"median":-25.163231,"eighty":-17.086749,"marketCap":6553608634},{"date":"2025-10-31","current":-18.557636,"twenty":-35.134293,"median":-25.089064,"eighty":-17.091971,"marketCap":7078531848},{"date":"2025-11-07","current":-18.27413,"twenty":-35.113548,"median":-25.061735,"eighty":-17.100484,"marketCap":6970392767},{"date":"2025-11-14","current":-18.0473,"twenty":-35.078925,"median":-25.005225,"eighty":-17.167513,"marketCap":6883871776},{"date":"2025-11-21","current":-20.58818,"twenty":-35.046287,"median":-24.960451,"eighty":-17.205458,"marketCap":7853052287},{"date":"2025-11-28","current":-20.832165,"twenty":-35.019071,"median":-24.831986,"eighty":-17.234059,"marketCap":7946116882},{"date":"2025-12-05","current":-21.755868,"twenty":-34.970678,"median":-24.804256,"eighty":-17.250726,"marketCap":8298449567},{"date":"2025-12-12","current":-21.562456,"twenty":-34.915285,"median":-24.794028,"eighty":-17.260737,"marketCap":8224675217},{"date":"2025-12-19","current":-20.64629,"twenty":-34.892419,"median":-24.779765,"eighty":-17.290194,"marketCap":7875217767},{"date":"2025-12-26","current":-21.531917,"twenty":-34.8916,"median":-24.750148,"eighty":-17.320435,"marketCap":8213026635},{"date":"2026-01-02","current":-20.479345,"twenty":-34.884679,"median":-24.734689,"eighty":-17.343911,"marketCap":7811538854},{"date":"2026-01-09","current":-20.902817,"twenty":-34.842144,"median":-24.714754,"eighty":-17.370686,"marketCap":7973065853},{"date":"2026-01-16","current":-21.613354,"twenty":-34.777275,"median":-24.687901,"eighty":-17.458106,"marketCap":8244089519},{"date":"2026-01-23","current":-22.800296,"twenty":-34.755447,"median":-24.587852,"eighty":-17.471277,"marketCap":8696831059},{"date":"2026-01-30","current":-20.853954,"twenty":-34.755447,"median":-24.548323,"eighty":-17.478647,"marketCap":7954428122},{"date":"2026-02-06","current":-20.542458,"twenty":-34.739533,"median":-24.51381,"eighty":-17.497742,"marketCap":7835612589},{"date":"2026-02-13","current":-20.630003,"twenty":-34.71867,"median":-24.448096,"eighty":-17.500128,"marketCap":7869005190},{"date":"2026-02-20","current":-21.18581,"twenty":-34.663442,"median":-24.415729,"eighty":-17.508411,"marketCap":8081009376},{"date":"2026-02-27","current":-18.973555,"twenty":-34.610593,"median":-24.382811,"eighty":-17.53466,"marketCap":8070913939},{"date":"2026-03-06","current":-18.50575,"twenty":-34.543546,"median":-24.337125,"eighty":-17.551029,"marketCap":7871920310},{"date":"2026-03-13","current":-18.112089,"twenty":-34.518799,"median":-24.274595,"eighty":-17.570018,"marketCap":7704466098},{"date":"2026-03-20","current":-17.938361,"twenty":-34.510585,"median":-24.237361,"eighty":-17.579848,"marketCap":7630566117},{"date":"2026-03-27","current":-18.123178,"twenty":-34.507969,"median":-24.160683,"eighty":-17.579848,"marketCap":7709183118},{"date":"2026-04-02","current":-19.524093,"twenty":-34.437772,"median":-24.108782,"eighty":-17.586711,"marketCap":8305099985},{"date":"2026-04-10","current":-19.330035,"twenty":-34.358753,"median":-24.063901,"eighty":-17.601644,"marketCap":8222552134},{"date":"2026-04-17","current":-19.195118,"twenty":-34.322749,"median":-24.041638,"eighty":-17.609571,"marketCap":8165161723},{"date":"2026-04-24","current":-19.963958,"twenty":-34.270145,"median":-23.993876,"eighty":-17.610703,"marketCap":8492208448},{"date":"2026-05-01","current":-18.533472,"twenty":-34.238295,"median":-23.961531,"eighty":-17.656648,"marketCap":7883712860}],"updateTime":1777942010231},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NUVL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2632474006","title":"Nuvalent Chief Legal Officer Deborah Ann Miller sells $545,331 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2632474006","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632474006?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:32","pubTimestamp":1777667557,"startTime":"0","endTime":"0","summary":"Nuvalent Chief Legal Officer Deborah Ann Miller sold 5,500 Class A common shares on April 30, 2026.Disposals were priced at USD 99.13 and USD 99.57.Miller reported direct ownership of 59,634 Class A common shares following transactions.Filing also showed exercise of 5,500 stock options at USD 6.89 on April 30, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDLzbR8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvalent Chief Legal Officer Deborah Ann Miller sells $545,331 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632264723","title":"Nuvalent Chief Development Officer Darlene Noci sells USD 545,251 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2632264723","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632264723?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:31","pubTimestamp":1777667462,"startTime":"0","endTime":"0","summary":"Nuvalent Chief Development Officer Darlene Noci exercised stock options for 5,500 Class A shares at USD 27.85 on April 29, 2026.Noci sold 5,500 Class A shares on April 29, 2026 for weighted average prices ranging from USD 99.35 to USD 101.17.Holdings fell to 58,117 Class A shares following transactions.Derivative position declined to 92,329 stock options after option exercise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL3svB10:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvalent Chief Development Officer Darlene Noci sells USD 545,251 shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NUVL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631632593","title":"Guardant Health partners with Nuvalent on companion diagnostics development, commercialization support","url":"https://stock-news.laohu8.com/highlight/detail?id=2631632593","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631632593?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:23","pubTimestamp":1777551810,"startTime":"0","endTime":"0","summary":"Guardant Health entered a multi-year strategic collaboration with Nuvalent to develop companion diagnostics using Guardant Infinity platform.Deal supports Nuvalent global clinical studies using Guardant tissue and liquid biopsy tests.Parties will evaluate Guardant assays as potential companion diagnostics to support regulatory filings for Nuvalent investigational oncology candidates.Collaboration includes plans to support potential global commercialization of Nuvalent therapies, if approved, alongside Guardant companion diagnostics in major markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via Business Wire  on April 30, 2026, and is solely respo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL49FMbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4585","NUVL","GH","BK4551","BK4196","BK4535","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635679","title":"Canaccord Genuity Sticks to Their Buy Rating for Nuvalent (NUVL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635679?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:59","pubTimestamp":1777546751,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst John Newman maintained a Buy rating on Nuvalent today and set a price target of $126.00. According to TipRanks, Newman is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-nuvalent-nuvl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-nuvalent-nuvl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631536034","title":"Nuvalent announces annual shareholder meeting in virtual format","url":"https://stock-news.laohu8.com/highlight/detail?id=2631536034","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631536034?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:42","pubTimestamp":1777408942,"startTime":"0","endTime":"0","summary":"Nuvalent scheduled 2026 annual shareholder meeting for June 16, 2026, to be held in virtual format.Shareholders will vote on election of two Class II directors: Michael L. Meyers, Ron Squarer.Advisory vote set on executive compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLccvfLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629702098","title":"A Look At Nuvalent (NUVL) Valuation As Zidesamtinib NDA Acceptance Advances Late Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629702098","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629702098?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:11","pubTimestamp":1776823871,"startTime":"0","endTime":"0","summary":"Nuvalent (NUVL) is back in focus after the FDA accepted its New Drug Application for zidesamtinib in ROS1-positive NSCLC and set a Prescription Drug User Fee Act action date for September 18, 2026.\nSee our latest analysis for Nuvalent.\nThe FDA’s NDA acceptance and upcoming data presentations arrive after a 30-day share price return of 13.04% and a year-to-date share price return of 6.24%, while the 1-year total shareholder return of 50.06% and 3-year total shareholder return above 3x suggest...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nuvl/nuvalent/news/a-look-at-nuvalent-nuvl-valuation-as-zidesamtinib-nda-accept","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nuvl/nuvalent/news/a-look-at-nuvalent-nuvl-valuation-as-zidesamtinib-nda-accept","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SSI","DCF","BK4139","NUVL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629030759","title":"Nuvalent to present pivotal ALKOVE-1 neladalkib data in ALK+ NSCLC at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629030759","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629030759?lang=en_us&edition=fundamental","pubTime":"2026-04-21 22:33","pubTimestamp":1776782034,"startTime":"0","endTime":"0","summary":"Nuvalent scheduled pivotal results from ALKOVE-1 trial of neladalkib in TKI pre-treated advanced ALK-positive NSCLC for oral presentation at ASCO 2026 on May 29.Data presentation will focus on overall efficacy and safety outcomes, targeting a patient group with prior kinase-inhibitor exposure.Nuvalent also slated preliminary ARROS-1 results for zidesamtinib in advanced ROS1-positive solid tumors outside NSCLC for poster presentation at ASCO 2026 on May 30.Company positioned both readouts as near-term clinical catalysts for its ALK and ROS1 selective inhibitor portfolio.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via PR Newswire  on April 21, 2026, and is ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL2D9QMr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629614033","title":"Nuvalent Price Target Maintained With a $155.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629614033","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629614033?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:07","pubTimestamp":1776769620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2026 07:07 ET (11:07 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629796778","title":"Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Nuvalent (NUVL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629796778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629796778?lang=en_us&edition=fundamental","pubTime":"2026-04-21 02:40","pubTimestamp":1776710407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on COMPASS Pathways (CMPS) and Nuvalent (NUVL) with bul...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-pathways-cmps-and-nuvalent-nuvl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-pathways-cmps-and-nuvalent-nuvl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4588","BK4137","BK4581","BK4139","LU0128526141.USD","XLV","LABU","BK4585","NUVL","CMPS","XBI","HCSG","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628849187","title":"BRIEF-Nuvalent, Inc - Nuvalent Anticipates U.S. Commercial Launch Of Zidesamtinib In 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628849187","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628849187?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:35","pubTimestamp":1776458155,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvalent, Inc - Nuvalent Anticipates U.S. Commercial Launch Of Zidesamtinib In 2026April 17 (Reuters) - Nuvalent, Inc NUVL.O:NUVALENT, INC - NUVALENT ANTICIPATES U.S. COMMERCIAL LAUNCH OF ZIDESA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nFWN4100XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628784871","title":"Nuvalent to present preclinical data for zidesamtinib at AACR meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628784871","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628784871?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:05","pubTimestamp":1776456344,"startTime":"0","endTime":"0","summary":"Nuvalent (NUVL) announced new clinical and preclinical data for zidesamtinib, an investigational ROS1-selective inhibitor, to be presented during p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvalent-to-present-preclinical-data-for-zidesamtinib-at-aacr-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvalent-to-present-preclinical-data-for-zidesamtinib-at-aacr-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781103","title":"Nuvalent says zidesamtinib shows 41% response rate in pretreated ROS1+ lung cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781103","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781103?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:02","pubTimestamp":1776456121,"startTime":"0","endTime":"0","summary":"Nuvalent disclosed new clinical and preclinical findings for investigational ROS1 inhibitor zidesamtinib, with results scheduled for presentation at AACR Annual Meeting 2026 on April 21.Trial data showed zidesamtinib produced meaningful tumor responses in heavily pre-treated ROS1-positive non-small cell lung cancer patients, including those who had progressed on repotrectinib or taletrectinib.Responses were also reported in patients with brain metastases or ROS1 resistance mutations, supporting use in difficult-to-treat settings.Nuvalent said FDA accepted zidesamtinib NDA for adults with locally advanced or metastatic ROS1-positive NSCLC previously treated with at least 1 ROS1 TKI, with PDUFA date set for Sept. 18, 2026.Company expects potential US launch in 2026, with plans to submit additional data in second half of 2026 to support label expansion into TKI-nave patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUB","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL1l3qfy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781924","title":"Nuvalent, Inc - Nuvalent Anticipates U.S. Commercial Launch of Zidesamtinib in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781924?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:01","pubTimestamp":1776456115,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nFWN4100XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628901781","title":"Nuvalent says FDA accepts zidesamtinib NDA, sets Sept. 18 PDUFA date","url":"https://stock-news.laohu8.com/highlight/detail?id=2628901781","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628901781?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:01","pubTimestamp":1776456084,"startTime":"0","endTime":"0","summary":"FDA accepted Nuvalent NDA for zidesamtinib in locally advanced or metastatic ROS1-positive NSCLC previously treated with at least 1 ROS1 TKI.PDUFA target action date set for Sept. 18, 2026.Nuvalent expects a U.S. launch in 2026, pending FDA review.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL1H8Lm6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627656354","title":"Nuvalent CSO Henry Pelish disposes of USD 323,112 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627656354","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627656354?lang=en_us&edition=fundamental","pubTime":"2026-04-14 04:31","pubTimestamp":1776112275,"startTime":"0","endTime":"0","summary":"Nuvalent Chief Scientific Officer Henry E. Pelish reported sales of 3,093 Class A shares on April 9, 2026.A separate sale covered 900 shares at USD 105.Pelish reported direct ownership of 65,604 Class A shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL8xDCt1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvalent CSO Henry Pelish disposes of USD 323,112 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626992226","title":"Nuvalent CEO James Porter disposes of USD 3.1 million Class A shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2626992226","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626992226?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:31","pubTimestamp":1775680271,"startTime":"0","endTime":"0","summary":"Nuvalent President, CEO, Director James Richard Porter reported sales of 30,000 Class A shares on April 6, 2026.Disposals were executed at weighted average prices of USD 103.21 to USD 105.6 per share.Porter also exercised stock options for 30,000 shares at USD 18.93 to USD 27.85 per share.Holdings in Class A common stock ended at 324,879 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL59Ydll:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nuvalent CEO James Porter disposes of USD 3.1 million Class A shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NUVL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625034941","title":"Nuvalent Price Target Maintained With a $125.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2625034941","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625034941?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:59","pubTimestamp":1775653140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2026 08:59 ET (12:59 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625934015","title":"BRIEF-Nuvalent Announces Submission Of New Drug Application To FDA For Neladalkib In Tki Pre-Treated Advanced Alk-Positive Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2625934015","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625934015?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:55","pubTimestamp":1775559344,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvalent Announces Submission Of New Drug Application To FDA For Neladalkib In Tki Pre-Treated Advanced Alk-Positive NsclcApril 7 (Reuters) - Nuvalent, Inc NUVL.O:NUVALENT ANNOUNCES SUBMISSION O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q0F8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NUVL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625315934","title":"Nuvalent submits FDA NDA for neladalkib in pretreated ALK-positive lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625315934","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625315934?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:30","pubTimestamp":1775557828,"startTime":"0","endTime":"0","summary":"Nuvalent submitted a New Drug Application to FDA for neladalkib in TKI pre-treated advanced ALK-positive non-small cell lung cancer.Filing is supported by data from global ALKOVE-1 Phase 1/2 trial in previously treated patients.Neladalkib holds FDA breakthrough therapy designation for patients previously treated with 2 or more ALK inhibitors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL8VJg2T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","NUVL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625934327","title":"Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in Tki Pre-Treated Advanced Alk-Positive Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2625934327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625934327?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:30","pubTimestamp":1775557804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q0F8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","NUVL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":133,"code":"91000000","status":"200"}]}}